IMCRImmunocore Holdings plc

Nasdaq immunocore.com


$ 36.57 $ -0.87 (-2.31 %)    

Wednesday, 21-Aug-2024 15:26:18 EDT
QQQ $ 481.66 $ 0.54 (0.11 %)
DIA $ 408.78 $ -0.45 (-0.11 %)
SPY $ 560.01 $ 0.08 (0.01 %)
TLT $ 98.76 $ 0.08 (0.09 %)
GLD $ 232.14 $ 0.48 (0.21 %)
$ 37.1
$ 37.44
$ 36.59 x 100
$ 36.66 x 200
$ 36.00 - $ 37.47
$ 33.05 - $ 76.98
704,424
na
1.86B
$ 0.64
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-08-2024 03-31-2024 10-Q
3 02-28-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 oppenheimer-reiterates-outperform-on-immunocore-hldgs-raises-price-target-to-89

Oppenheimer analyst Jeff Jones reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Outperform and raises the price target from ...

 needham-reiterates-buy-on-immunocore-hldgs-maintains-81-price-target

Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.

 immunocore-hldgs-q2-2024-gaap-eps-023-beats-045-estimate-sales-75400m-beat-74580m-estimate

Immunocore Hldgs (NASDAQ:IMCR) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0....

 jp-morgan-maintains-overweight-on-immunocore-hldgs-lowers-price-target-to-66

JP Morgan analyst Jessica Fye maintains Immunocore Hldgs (NASDAQ:IMCR) with a Overweight and lowers the price target from $7...

 hc-wainwright--co-reiterates-buy-on-immunocore-hldgs-maintains-100-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $100 pri...

 needham-reiterates-buy-on-immunocore-hldgs-maintains-81-price-target

Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.

 hc-wainwright--co-reiterates-buy-on-immunocore-hldgs-maintains-100-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $100 pri...

 needham-reiterates-buy-on-immunocore-hldgs-maintains-81-price-target

Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.

 hc-wainwright--co-reiterates-buy-on-immunocore-hldgs-maintains-100-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $100 pri...

 needham-reiterates-buy-on-immunocore-hldgs-maintains-81-price-target

Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.

 mizuho-maintains-buy-on-immunocore-hldgs-lowers-price-target-to-88

Mizuho analyst Graig Suvannavejh maintains Immunocore Hldgs (NASDAQ:IMCR) with a Buy and lowers the price target from $90 to...

 canaccord-genuity-maintains-hold-on-immunocore-hldgs-raises-price-target-to-67

Canaccord Genuity analyst Bill Maughan maintains Immunocore Hldgs (NASDAQ:IMCR) with a Hold and raises the price target from...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION